{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T07:15:08Z","timestamp":1766819708231,"version":"3.37.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["112-2314-B-002-30","111-2314-B-002-288","112-2314-B-002-MY3"],"award-info":[{"award-number":["112-2314-B-002-30","111-2314-B-002-288","112-2314-B-002-MY3"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["109-HCH025","109-HCH068","111-HCH037","109-HCH003","110-HCH001","111-HCH010","109-HCH057","109-HCH001"],"award-info":[{"award-number":["109-HCH025","109-HCH068","111-HCH037","109-HCH003","110-HCH001","111-HCH010","109-HCH057","109-HCH001"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.kint.2024.10.023","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:56:39Z","timestamp":1731722199000},"page":"348-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access"],"prefix":"10.1016","volume":"107","author":[{"given":"Tsung-Yu","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7833-847X","authenticated-orcid":false,"given":"Mu-Yang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.10.023_bib1","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.10.023_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI Clinical Practice Guideline for Vascular Access: 2019 update","volume":"75","author":"Lok","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.10.023_bib3","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/ki.1997.499","article-title":"Predictive measures of vascular access thrombosis: a prospective study","volume":"52","author":"May","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.023_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.V311","article-title":"Vascular access: concepts for the 1990s","volume":"3","author":"Fan","year":"1992","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/j.ajkd.2021.12.017","article-title":"Association of frailty with thrombosis of hemodialysis vascular access: a prospective Taiwanese cohort study","volume":"80","author":"Luo","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.10.023_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47293-3","article-title":"Temporal distribution and biological determinants of thrombotic events after interventions for dialysis vascular access","volume":"9","author":"Hsieh","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2024.10.023_bib7","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jvir.2016.07.015","article-title":"Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit","volume":"27","author":"Dariushnia","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.kint.2024.10.023_bib8","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/01.ASN.0000081661.10246.33","article-title":"Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis","volume":"14","author":"Kaufman","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib9","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00270-018-2046-5","article-title":"Thrombophilia associated with early post-angioplasty thrombosis of dialysis vascular access","volume":"41","author":"Chen","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.kint.2024.10.023_bib10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2215\/CJN.03860412","article-title":"Thrombophilia and arteriovenous fistula survival in ESRD","volume":"8","author":"Salmela","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1681\/ASN.2017080929","article-title":"Uremic solute-aryl hydrocarbon receptor-tissue factor axis associates with thrombosis after vascular injury in humans","volume":"29","author":"Kolachalama","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib12","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1097\/01.ASN.0000027356.16598.99","article-title":"Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial","volume":"13","author":"Crowther","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2024.10.023_bib14","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2020111566","article-title":"Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial","volume":"32","author":"De Vriese","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2024.10.023_bib16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/ATVBAHA.119.313879","article-title":"Warfarin accelerates medial arterial\u00a0calcification in humans","volume":"40","author":"Alappan","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2024.10.023_bib17","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1681\/ASN.2016090980","article-title":"Apixaban pharmacokinetics at steady state in hemodialysis patients","volume":"28","author":"Mavrakanas","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.10.023_bib19","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jacc.2009.07.010","article-title":"2009 ACCF\/AHA focused update on perioperative beta blockade incorporated into the ACC\/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery","volume":"54","author":"Fleisher","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2024.10.023_bib20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.10.023_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(03)00415-3","article-title":"Adapting the Charlson Comorbidity Index for use in patients with ESRD","volume":"42","author":"Hemmelgarn","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.10.023_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.ajkd.2018.01.034","article-title":"Medicare costs associated with arteriovenous fistulas among US hemodialysis patients","volume":"72","author":"Thamer","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.10.023_bib23","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa0805840","article-title":"Effect of dipyridamole plus aspirin on hemodialysis graft patency","volume":"360","author":"Dixon","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.10.023_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1681\/ASN.2010060582","article-title":"Use of aspirin associates with longer primary patency of hemodialysis grafts","volume":"22","author":"Dixon","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib25","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.299.18.2164","article-title":"Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial","volume":"299","author":"Dember","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2024.10.023_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5301\/jva.5000660","article-title":"Initiation of antiplatelet medication after surgical thrombectomy jeopardized arteriovenous graft longevity","volume":"18","author":"Yeh","year":"2017","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.kint.2024.10.023_bib27","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.023_bib28","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1681\/ASN.2010101119","article-title":"Intradialytic hypotension and vascular access thrombosis","volume":"22","author":"Chang","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.kint.2015.12.019","article-title":"The molecular mechanisms of\u00a0hemodialysis vascular access failure","volume":"89","author":"Brahmbhatt","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.023_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2015010068","article-title":"Serum indoxyl sulfate associates with postangioplasty thrombosis of dialysis grafts","volume":"27","author":"Wu","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.023_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2012.08.031","article-title":"Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis","volume":"61","author":"Palmer","year":"2013","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824007920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824007920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T20:20:36Z","timestamp":1737577236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824007920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0085253824007920"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.10.023","relation":{},"ISSN":["0085-2538"],"issn-type":[{"type":"print","value":"0085-2538"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}